CAS 1001424-68-5: 9H-Xanthen-9-one, 1,4,5,6-tetrahydroxy-7-(3-methyl-2-buten-1-yl)-

1,4,5,6-Tetrahydroxy-7-prenylxanthone displays moderate anti-cancer effects on breast, lung, and leukaemic cells in vitro.

1,4,5,6-Tetrahydroxy-7-prenylxanthone is a naturally occurring xanthone derivative, which is predominantly sourced from certain plant species such as Garcinia and related genera. This compound is characterized by its unique chemical structure that includes a prenyl group, contributing to its biological activity. The mode of action of 1,4,5,6-Tetrahydroxy-7-prenylxanthone involves its potent antioxidant capabilities. It can scavenge free radicals, thereby mitigating oxidative stress within biological systems. Additionally, its chemical structure allows for interactions with various molecular pathways, potentially exhibiting anti-inflammatory and antimicrobial effects. In terms of applications, 1,4,5,6-Tetrahydroxy-7-prenylxanthone is of particular interest in the pharmaceutical and nutraceutical fields. Researchers are investigating its potential in developing treatments for oxidative stress-related diseases and exploring its role in natural health products. Given its diverse modes of action, this compound is a valuable candidate for further studies into new therapeutic agents targeting a wide range of conditions.